Clover Health Investments (CLOV) CORRESP Correspondence with SEC

5401 Mallory Lane, Suite 210

Franklin, TN 37067

November 15, 2021

VIA EDGAR

U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

Attn:    J. Nolan McWilliams

Justin Dobbie

Re: Clover Health Investments, Corp. Registration Statement on Form S-1 File No. 333-261078 REQUEST FOR ACCELERATION OF EFFECTIVENESS

Acceleration Request

    Requested Date:    November 17, 2021
    Requested Time:    4:30 p.m. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Clover Health Investments, Corp. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-261078) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.

The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.

The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.

[Signature page follows]

Sincerely,

Clover Health Investments, Corp.

By: /s/ Mark Herbers

    Name: Mark Herbers

    Title: Chief Financial Officer

cc:	Vivek Garipalli, Clover Health Investments, Corp
	Andrew Toy, Clover Health Investments, Corp.
	Gia Lee, Clover Health Investments, Corp.
	Stephen Thau, Esq., Orrick, Herrington & Sutcliffe LLP
	William L. Hughes, Esq., Orrick, Herrington & Sutcliffe LLP
	Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP